Dexrazoxane inhibits the growth of esophageal squamous cell carcinoma by attenuating SDCBP/MDA-9/syntenin-mediated EGFR-PI3K-Akt pathway activation
Article in Scientific Reports (April 2024)
The most recent citing publications are shown below. View all 60 publications that cite this research output on Dimensions.
Massively parallel identification of single-cell immunophenotypes
Preprint in bioRxiv (April 2024)
Network pharmacology and molecular docking reveal the mechanisms of curcumin activity against esophageal squamous cell carcinoma
Article in Frontiers in Pharmacology (April 2024)